178 related articles for article (PubMed ID: 22136472)
1. Successful immunostaining demonstrates abnormal intracytoplasmic MYH9 protein (NMMHC-IIA) in neutrophils of a dog with May-Hegglin anomaly.
Flatland B; Kunishima S
Vet Clin Pathol; 2011 Dec; 40(4):409-410. PubMed ID: 22136472
[No Abstract] [Full Text] [Related]
2. An interesting case of thrombocytopenia in pregnancy.
Garcia-Horton A; Chin-Yee I; Lam S
Int J Hematol; 2020 Aug; 112(2):139-140. PubMed ID: 32557127
[No Abstract] [Full Text] [Related]
3. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
4. May-Hegglin anomaly in a dog.
Flatland B; Fry MM; Baek SJ; Bahn JH; LeBlanc CJ; Dunlap JR; Carroll RC; Kosiba DJ; Millsaps DJ; Schleis SE
Vet Clin Pathol; 2011 Jun; 40(2):207-14. PubMed ID: 21554370
[TBL] [Abstract][Full Text] [Related]
5. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
6. Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings of MYH9-Related Disease.
Ruhoy SM; Yates A
Lab Med; 2016 Aug; 47(3):246-50. PubMed ID: 27353381
[TBL] [Abstract][Full Text] [Related]
7. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
8. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
Kunishima S; Hirano K; Hamaguchi M; Saito H
Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
[No Abstract] [Full Text] [Related]
10. A notable case report of May-Hegglin anomaly with immune complex-related nephropathy: a genetic and histological analysis.
Ohtsuka Y; Kanaji T; Nishi M; Sakai N; Sato T; Aoki S; Wakayama K; Nakazato S; Hisano S; Sado Y; Kawachi H; Izuhara K; Hamasaki Y
Clin Nephrol; 2011 Mar; 75(3):255-62. PubMed ID: 21329637
[TBL] [Abstract][Full Text] [Related]
11. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
Wasano K; Matsunaga T; Ogawa K; Kunishima S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
[TBL] [Abstract][Full Text] [Related]
12. A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan.
Huang YC; Shih YH; Lin CY; Chiu PF; Kuo SF; Lin JS; Shen MC
Int J Hematol; 2020 Dec; 112(6):878-882. PubMed ID: 32712863
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
[TBL] [Abstract][Full Text] [Related]
14. MYH9 gene mutations associated with bleeding.
Savoia A; De Rocco D; Pecci A
Platelets; 2017 May; 28(3):312-315. PubMed ID: 28368695
[No Abstract] [Full Text] [Related]
15. Renal manifestations of patients with MYH9-related disorders.
Han KH; Lee H; Kang HG; Moon KC; Lee JH; Park YS; Ha IS; Ahn HS; Choi Y; Cheong HI
Pediatr Nephrol; 2011 Apr; 26(4):549-55. PubMed ID: 21210153
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.
Kunishima S; Hamaguchi M; Saito H
Blood; 2008 Mar; 111(6):3015-23. PubMed ID: 18192507
[TBL] [Abstract][Full Text] [Related]
17. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Seri M; Pecci A; Di Bari F; Cusano R; Savino M; Panza E; Nigro A; Noris P; Gangarossa S; Rocca B; Gresele P; Bizzaro N; Malatesta P; Koivisto PA; Longo I; Musso R; Pecoraro C; Iolascon A; Magrini U; Rodriguez Soriano J; Renieri A; Ghiggeri GM; Ravazzolo R; Balduini CL; Savoia A
Medicine (Baltimore); 2003 May; 82(3):203-15. PubMed ID: 12792306
[TBL] [Abstract][Full Text] [Related]
18. Identification of the first in cis mutations in MYH9 disorder.
Miyajima Y; Kunishima S
Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
[TBL] [Abstract][Full Text] [Related]
19. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
20. MYH9 Associated nephropathy.
Furlano M; Arlandis R; Venegas MDP; Novelli S; Crespi J; Bullich G; Ayasreh N; Remacha Á; Ruiz P; Lorente L; Ballarín J; Matamala A; Ars E; Torra R
Nefrologia (Engl Ed); 2019; 39(2):133-140. PubMed ID: 30471777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]